Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Similar documents
EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

ORAL DOSAGE OVERVIEW

The binding performance of DFE Pharma Starch

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

STARCH Application Data

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

REVISION OF MONOGRAPH ON TABLETS. Tablets

Formulation and Evaluation

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

TABLET DESIGN AND FORMULATION

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

Formulation and evaluation of oro-dispersible tablets of lafutidine

SUMMARY AND CONCLUSION

The unlocked synergy of DFE Pharma MCC

Effect of Compaction Forces on Powder Bed Permeability of Magnesium Silicate "Common Excipient Mixture"

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

BPCA: Best Pharmaceuticals For Children Act. Exclusivity incentives, public disclosure of study results. Paper. Remedy unauthorized pediatric med use

Technical brochure StarLac

Re-compaction properties of lactose and microcrystalline cellulose

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

Easy, fast and reliable!

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

Starch Applications in Meat Products. Kris J. Swenson Tom Katen

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Easy, fast and reliable!

Studies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone

Journal of Chemical and Pharmaceutical Research

Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M. Super-disintegrants and dissolution enhancers.

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Primellose is an excellent choice as superdisintegrant in ODT applications

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

Formulation and evaluation of immediate release salbutamol sulphate

DEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED RELEASE AGENT FOR TABLETS

Effect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet

J.Ayyappan et al, /J. Pharm. Sci. & Res. Vol.2 (7), 2010,

African Journal of Pharmaceutical Research & Development

( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1

Development and characterization of orodispersible tablets of famotidine containing a subliming agent

Available online through

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

Design and development of fast Melting Tablets of Terbutaline Sulphate

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

Available online Research Article

Formulation Development and Evaluation of Ondansetron Hcl Fast Dispersing Tablets for Treatment of Chemotherapy

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

Continuous Granulation Using a Twin-Screw Extruder. Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016

Technical brochure CombiLac

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

Asian Journal of Research in Pharmaceutical Sciences and Biotechnology

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Formulation and evaluation of fast dissolving tablet of aceclofenac

(51) Int Cl.: A61K 9/00 ( ) A61K 9/20 ( ) A61K 31/00 ( )

IJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Office europeen des brevets. Publication number: Applicant: Chugai Seiyaku Kabushiki Kaisha 5-1, 5-chome, Ukima Kita-ku Tokyo(JP)

Formulation and Evaluation of Mouth Dissolving Sublingual Tablets of Cimetidine to Treat Abdominal Cramps

Compression and Mechanical Properties of Tablet Formulations

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Oral Disintegrating Minitablets: Mini Review

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2009/36

KING KHALID UNIVERSITY

Volker Bühler. Pharmaceutical Technology of BASF Excipients. Pharma Ingredients &Services. Welcome to more opportunities.

DISCIPLINE RECORD/ COURSE / SEMINAR DESCRIPTION

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014

A study of compressibility and compactibility of directly compressible tableting materials containing tramadol hydrochloride

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

SCIENTIFIC DISCUSSION. Efavirenz

FLORITER. New Technology for Innovative Formulation Design.

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS

Graphical Abstract. Final Step. Iwao et al. First Step Disintegrant. Second Step. Available surface area (St) using the data of dissolution study

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Formulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate

Evaluation of native and modified starch dispersions in mucilage obtained from sweet potato in ascorbic acid chewable tablet formulations

I International Bureau (10) International Publication Number (43) International Publication Date

Animal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation

LAB.2. Tablet Production Methods

Carbohydrate Chemistry 2016 Family & Consumer Sciences Conference Karin Allen, PhD

Evaluation of Terminalia randii Baker F. gum as a disintegrant in paracetamol tablet formulation

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

Transcription:

57. Starch Convention, Detmold, April 26-28, 2006 K.-J. Steffens Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Starches, Pharmaceutical Applications _ Starches used in pharmaceutical preparations: Corn Starch Potatoe Starch Rice Starch Wheat Starch Pea Starch (soon in Pharmacopoeia) Native starches are mainly used as fillers and disintegrants in tablets and capsules, sometimes as fillers in dermatological powders.

Starches, Pharmaceutical Applications _ Modified Starches, Pregelatinated Starches: Dextrins and Maltodextrins are used as fillers and binders in tablets, as thickeners in liquid preparations. Starch paste is widely used as binder in tablets.

Starches, Pharmaceutical Applications _ Starch Derivates: Hydroxyethyl-starch (HES) Na-Carboxymethyl-starch, crosslinked Hydroxypropyl-beta-cyclodextrin plasma expander super-disintegrant in tablets complexing agent in several preparations

Starches as Binder for Wet Granulation pharmapedia.com : Freshly prepared starch paste is used as a binder. - Its method of preparation is very crucial.

Potatoe Starch, Water, 20 C

Swelling of Potatoe Starch, Water, 75 C

Swelling of Potatoe Starch, Water, 95 C

Swelling of Starch in Water, 95 C _ Starch paste is not a complete solution. It is a dispersion of swollen starch grains. A part of amylose is in solution inside the swollen sacks and can leave them by diffusion. Amylose and amylopectine is partially degraded. Until usage retrogradation occurs All these phenomena are influenced by temperature, kinetics of cooking and time until usage. A starch paste with constant properties can hardly be achieved. Solution: Pregelatinzed or modified starches

Comparison Lycatab DSH versus Kollidon 30

Comparison Lycatab DSH versus Kollidon 30

Starches and Modified Starches as Binders for Wet Granulation Properties (compared to other binders): Sufficient binding capacity Extremely low potential of incompatibilities Stable properties during shelf life of tablets Positive influence on tablet disintegration Positive influence on dissolution of actives Low concentrations of lubricants for tableting Long service life for tableting tools Sensitive to magnesium stearate film forming

Continuous Wet Granulator, based on a Planetary Roller Extruder

Continuous Wet Granulator, based on a Planetary Roller Extruder vacuum nitrogen granulation liquid powder blend DRYING GRANULATION SIEVING

Planetary Roller Extruder, side view

Planetary Roller Extruder, front view

Formulation of Ibuprofen Tablets with Starch as a Wet Binder Formulation Ibuprofen 92.0 % Granules Cellulose Powder 3.0 % Starch (Eurylon 7) 5.0 % Water 14.0 % Final Blend Magnesium Stearate 0.5 % Sodium Carboxymethyl Starch (Explotab) 5.0 % Starch is completely gelatinized Temperature: < 40 C Final Tablet contains 87.6 % of ibuprofen

Ibuprofen Tablets, Compression Profile 3,5 3 Tensile Strength (N/mm²) 2,5 2 1,5 Disintegration > 20 min Disintegration > 5 min Disintegration > 1.5 Ibuprofen Granules: Bohle 28.09.2004 + 0.5% Mg-Stearate + 5.0% Explotab 1 Disintegration < 30 - P1200, 24 Eu19 Punch 9.0 mm, Radius 15 mm - Speed: 30 Rpm - Tablet Weigt: 200 mg, Filling Depth: 7 mm - Precompression:~10% of Maincompression 0,5 0 20 40 60 80 100 120 140 160 180 200 Compression Presssure (MPa)

1. Conclusion Especially modified starches deserves serious consideration as binders in solid dosage forms wet granulation.

Co-Processed Excipient, StarLac, 85% Lactose, 15% Corn Starch

StarLac, 85% Lactose, 15% Corn Starch (coprocessed)

StarLac, Disintegration Time of Tablets versus Compression Force Disintegration time (+1.0% Mg-stearate) 03' 30'' 03' 00'' 02' 30'' Physical Mixture disintegration time 02' 00'' 01' 30'' 01' 00'' 00' 30'' StarLac 00' 00'' 8 10 12 14 16 18 20 22 compression force [kn] Starlac corn starch + Flowlac

StarLac, Influence of Magnesium Stearate 02' 53'' 02' 36'' Physical Mixt., 0.5 % Mg-Stearate 02' 18'' Disintegration Time [s] 02' 01'' 01' 44'' 01' 26'' 01' 09'' 00' 52'' 00' 35'' 00' 17'' Physical Mixt., 0.1 % Mg-Stearate StarLac, 0.5 % Mg-Stearate StarLac, 0.1 % Mg-Stearate 00' 00'' 0 20 40 60 80 100 120 140 160 180 Tablet Crushing Strength [N] StarLac 0,5% Mg-Stearat Physikalische Mischung 0,5% Mg-Stearat StarLac 0,1 Mg-Stearat% Physikalische Mischung 0,1% Mg-Stearat

StarLac, Orodispersible Tablets Orodispersible tablets: Tablets to be placed in the mouth where they disperse rapidly before swallowing

StarLac, Orodispersible Tablets, Measurement of Functionality (Roquette) Tablet ist placed in a metal beaker A piston (5 mm) presses on the Tablet ( 5 N) 2 ml water is added Force versus time curve is measured)

StarLac, Orodispersible Tablets Porosity controlled: swelling and collapse Viscosity controlled: continous melting

StarLac, Orodispersible Tablets

StarLac, Orodispersible Tablets

Lycoat, Film-Former for Coated Tablets Lycoat: Pea Starch with ideal amylose content Hydroxypropylated to avoid starch retrogradation

Lycoat, Film Properties

Conclusions Starch, modified starches and starch derivates deserves more attention regarding their outstanding functionalities beyound their classical usage as binder and disintegrant in pharmaceutical preparations.